INSIGHTS ON DRUG DISCOVERY

• WuXia293Stable: Express What CHO Can't

  Explore a modern 293‑based expression system built for higher purity, controlled glycosylation, and improved activity, offering a new option for teams developing complex or next‑generation biologics.

• What Matters More In DNA-Encoded Libraries?

  DELs can screen billions of compounds, but library quality determines meaningful results. See how thoughtful design shapes early decisions that influence which drug candidates move forward.

• Translating Massive Data Into Therapeutic Momentum

  New advances in chemomics, proteome mapping, and modern synthetic methods are redefining how quickly and precisely discovery teams can move from raw data to meaningful clinical momentum.

• ADCs: Overcoming Analytical Challenges In Next-Gen Cancer Therapies

  Antibody-Drug Conjugates (ADCs) represent a revolutionary approach in cancer treatment. But with innovation comes complexity. 

• From Promise To Patients: Smarter Pathways To Scale In Cell And Gene Therapy Manufacturing

  2/12/2026

  As the field evolves, the strategies developers choose may prove just as influential as the therapies themselves in determining how quickly innovation reaches patients.

• The Science Of Cell Line Development For Biologics

  2/12/2026

  Selecting and engineering the right cell line is not simply a technical milestone; it is a strategic decision that shapes cost of goods, development timelines, and the overall probability of success.

• The Gateway Delivery To The Brain

  1/30/2026

  Nose‑to‑brain delivery enables targeted neurological treatment by using direct neural pathways to boost precision and limit systemic exposure, with new formulations and devices driving rapid progress.

• Covalent Warhead Reactivity: A New Look At GSH Reactivity Assays

  1/26/2026

  Understanding covalent warhead kinetics is key to reducing safety risks early in discovery. Learn about a new approach to GSH‑based measurements that offers clearer predictors of toxicity.

• Flow Chemistry For Contemporary Isotope Labeling

  1/26/2026

  Gain insight into how late‑stage exchange and flow‑based methods enable efficient access to labeled molecules for pharmaceuticals, mechanistic studies, and analytical applications.